Results 251 to 260 of about 122,119 (386)

Neutrophil inflammation metrics are associated with the risk of future dementia in large data from NYU Langone Hospitals and the Veterans Health Administration

open access: yesAlzheimer's &Dementia, Volume 22, Issue 4, April 2026.
Abstract INTRODUCTION Neutrophil‐to‐lymphocyte ratio (NLR), a marker of systemic inflammation, has been linked to dementia risk, but prior studies were limited by small sample sizes. METHODS We assessed the association between baseline NLR and incident Alzheimer's disease (AD) and Alzeimer's disease and related dementias (AD/ADRD) using electronic ...
Tianshe He   +16 more
wiley   +1 more source

Alzheimer's disease and related dementias and related health conditions among American Indian and Alaska Native Medicare beneficiaries

open access: yesAlzheimer's &Dementia, Volume 22, Issue 4, April 2026.
Abstract INTRODUCTION Alzheimer's disease and related dementias (ADRD) and its associated factors are not well understood in the American Indian and Alaska Native (AI/AN) population. METHODS We analyzed Medicare 2019 data for 112,280 AI/AN and 1,010,862 White beneficiaries aged 68+, examining the prevalence of ADRD‐related health conditions and their ...
Manxi Yang   +7 more
wiley   +1 more source

TAVR in Male Patients With Large Aortic Valve Annuli: A Propensity‐Matched Analysis of Balloon‐Expandable Versus Self‐Expanding Valves

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 5, Page 1506-1513, April 1, 2026.
ABSTRACT Background Trans‐catheter aortic valve replacement (TAVR) in patients with large annuli poses procedural difficulties and possible complications. Aims We sought to compare the peri‐procedural and long‐term outcomes of patients with large annuli undergoing TAVR with self‐expanding (SEV) versus balloon‐expandable (BEV) valves.
Lior Zornitzki   +12 more
wiley   +1 more source

Cerebral Embolic Protection Devices (CEPDs) During Transcatheter Aortic Valve Implantation (TAVI): A Meta‐Analysis of Randomized Controlled Trials

open access: yesClinical Cardiology, Volume 49, Issue 4, April 2026.
This meta‐analysis of eight RCTs (n = 11,589) demonstrates that the routine use of cerebral embolic protection devices during TAVI does not significantly reduce the risk of overall, disabling, or non‐disabling stroke, nor does it confer a mortality benefit.
Mohamed Ibrahim Gbreel   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy